TREA

90031603 - WUXIDAR4

Follow

Information

  • Trademark
  • 90031603
  • Serial Number
    90031603
  • Registration Number
    6512549
  • Filing Date
    July 01, 2020
    4 years ago
  • Registration Date
    October 05, 2021
    3 years ago
  • Transaction Date
    April 06, 2023
    a year ago
  • Status Date
    October 05, 2021
    3 years ago
  • Published for Opposition Date
    January 19, 2021
    3 years ago
  • Location Date
    August 31, 2021
    3 years ago
  • First Use Anywhere Date
    September 25, 2020
    4 years ago
  • First Use In Commerce Date
    September 25, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    WHEATLEY, TRAVIS DWIGH
  • Attorney Docket Number
    0904-0185US1
    Attorney Name
    Michael T. Smith
    Law Office Assigned Location Code
    O10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
WUXIDAR4
Case File Statements
  • GS0051: pharmaceutical preparations for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; drugs for medical purposes, namely, anticancer drugs; biological preparations for medical purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; medicines for human purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Biochemical medicines for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Antibody drug for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; multispecific antibody for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; multispecific antibody format for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; medicines for veterinary purposes for treatment of canine disease; biological preparations for veterinary purposes for treatment of canine disease
  • PM0001: WUXIDAR FOUR
  • GS0421: Product development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; Biochemical research and analysis; Biomedical research services; development of pharmaceutical preparations and medicines; Research and development of antibodies
Case File Event Statements
  • 4/5/2023 - a year ago
    28 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 10/5/2021 - 3 years ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/1/2021 - 3 years ago
    26 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 8/31/2021 - 3 years ago
    25 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 8/27/2021 - 3 years ago
    24 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 8/24/2021 - 3 years ago
    23 - USE AMENDMENT FILED Type: IUAF
  • 8/26/2021 - 3 years ago
    22 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 8/24/2021 - 3 years ago
    21 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 3/16/2021 - 3 years ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/19/2021 - 3 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/19/2021 - 3 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/30/2020 - 3 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/11/2020 - 3 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/9/2020 - 3 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/8/2020 - 3 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/8/2020 - 3 years ago
    13 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 11/28/2020 - 3 years ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 11/28/2020 - 3 years ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 11/28/2020 - 3 years ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 10/21/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/20/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/20/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/25/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/25/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/25/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/13/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/29/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/4/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP